Last reviewed · How we verify

NCT04756583

Advance Care Planning Notifications in General Inpatient Medicine

Completed NA Last updated 17 October 2024
What this trial tests

NA trial testing Notification system in Advance Care Planning in 73 participants. Completed in 30 June 2023.

Timeline
15 February 2021
Primary endpoint
31 December 2022
30 June 2023

Quick facts

Lead sponsorDuke University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment73
Start date15 February 2021
Primary completion31 December 2022
Estimated completion30 June 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Duke University

Who can join

18 and older, any sex, with Advance Care Planning. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate the impact of and response by physicians on Hospital Medicine/General Internal Medicine service to a notification identifying seriously ill patients at high risk of death within 30 days as well as within 6 months in a cluster randomized control trial.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Advance Care Planning

Currently open trials in the same condition.

Other Duke University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04756583.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing